GRO (Brazil Potash Corp.) arrives at its May 20 earnings event having shed nearly 19% over the past month, with the stock closing at $2.50 — near the bottom of its recent range.
The price slide is the dominant story heading into the print. GRO fell another 6.7% on Tuesday and is down 8.4% on the week, underperforming most of its closest correlated peers. SQM dropped 15% on the week and IPI fell 11.5%, so broader fertilizer-sector weakness provides some context — but GRO's drawdown has been sharper and more persistent over the month.
Short interest is not the story here. At just 0.54% of free float, bearing pressure from the lending market is minimal. Borrow costs run at 4.1%, modestly up on the week but unremarkable for a small-cap development company. Availability is loose at roughly 660% of short interest, meaning there are far more shares available to lend than are actually borrowed — no squeeze dynamic is in play. The ORTEX short score of 41, down from a recent peak near 46, confirms the short-side thesis has been losing momentum.
The more meaningful angle is in the ownership register and the historical reactions to announcements. Goldman Sachs built a near-5% stake in Q1, adding over 3.1 million shares from a near-zero base — an unusually large new position for a $160m development-stage name. That stands against Alyeska, which cut its holding by 1.9 million shares over the same period. Past announcement events have consistently delivered positive first-day moves: the last four saw gains of 8.6%, 7.5%, 15.5%, and 4.0% respectively on announcement day. The five-day outcomes, however, have been mixed — one event produced a 7% fade after the initial pop.
Analyst data is stale: the most recent coverage change on record dates to December 2025, when Cantor Fitzgerald initiated with a Speculative Buy at $2.75. Roth MKM had a Buy rating but cut its target sharply from $17 to $5.50 in April 2025 — data that is now over a year old and should not be taken as current guidance on valuation.
The print will test whether the project narrative around the Autazes potash development can arrest the stock's month-long decline, or whether the gap between the Goldman entry price and today's close simply widens further.
See the live data behind this article on ORTEX.
Open GRO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
